Press release
Peptide Therapeutics Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Peptide Therapeutics Market Size
What Is the Peptide Therapeutics Market Size and Projected Growth Rate?
The size of the peptide therapeutics market has experienced swift expansion in recent years. It is forecasted to increase from $45.15 billion in 2024 to $49.67 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.0%. The acceleration in growth during the historical period is linked to the rising occurrence of chronic illnesses, a deepening comprehension of molecular biology, and the broadening use of peptide therapeutics in the field of oncology.
The market size of peptide therapeutics is anticipated to experience swift expansion in the coming years, with projections indicating a value of $76.64 billion in the year 2029, reflecting a compound annual growth rate (CAGR) of 11.5%. This forthcoming growth can be linked to an increasing demand for personalized medicine, wider immunotherapy applications, continuous improvements in peptide delivery systems, the emergence of peptide targets for infectious diseases, and an intensified focus on rare diseases. The forecast period is expected to see trends such as advanced techniques in peptide synthesis, heightened investment and funding, a focus on the safety of peptide drugs, market growth in developing economies, and the inclusion of artificial intelligence (AI).
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216
What Are the Major Segments in the Peptide Therapeutics Market?
The peptide therapeutics market covered in this report is segmented -
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
What Are The Driving Peptide Therapeutics Market Evolution?
The expected rise in chronic diseases is set to drive the expansion of the peptide therapeutics market. Chronic diseases, which are often long-term afflictions that are typically incurable but occasionally treatable and manageable, are becoming increasingly prevalent due to factors such as tobacco usage, poor diet, physical inactivity, excessive alcohol consumption, among others. The application of peptide therapeutics assists in preventing and treating these chronic diseases. For example, the National Library of Medicine, a US agency, reported in January 2023 that the population of those aged 50 and above in the US with at least one chronic disease is anticipated to jump by 99.5% to 142.66 million by 2050. Consequently, the predicted upturn in the frequency of chronic diseases is foreseen to bolster the peptide therapeutics market throughout the forecast timeframe.
Which Firms Dominate The Peptide Therapeutics Market Segments?
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
What Trends Are Driving Growth in The Peptide Therapeutics Market?
Major businesses in the peptide therapeutics market are concentrating their efforts on launching state-of-the-art solutions like cell culture technology to gain a better position, and succeed in the market. Cell culture technology refers to the method of cultivating cells outside their natural environment, under closely monitored conditions. This involves extracting the cells of interest from living tissues and keeping them alive afterwards. For example, Evonik Industries AG, a specialty chemicals company based in Germany, in June 2023, introduced cQrex KC. cQrex KC is a next-generation peptide developed specifically for biopharmaceutical applications and is suitable for cell culture procedures used in producing biological drugs. It aids cell culture process developers in perfecting cystine supply while also improving cell culture productivity. cQrex KC contributes to the growth of vaccines, viral vectors and cell therapies.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
Which Is The Largest Region In The Peptide Therapeutics Market?
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peptide Therapeutics Market?
2. What is the CAGR expected in the Peptide Therapeutics Market?
3. What Are the Key Innovations Transforming the Peptide Therapeutics Industry?
4. Which Region Is Leading the Peptide Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4015454 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
